| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Gliclazide 30mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| bendrofluazida+potasio, 2,5 mg/8,4 mmol, comprimido de liberación modificada |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Diclofenac sodium 50mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Lovastatin 20mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Theophylline anhydrous 450mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Clarithromycin 1000mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Mizolastine 10mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Isradipine m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Nifedipine 30mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Ciprofloxacin 500mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Methylphenidate hydrochloride 27mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Doxazosin 4mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Lovastatin 60mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Metoprolol succinate 200mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Oxycodone hydrochloride 40mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Metoprolol succinate 100mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Oxprenolol hydrochloride 160mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Etodolac 600mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Methylphenidate hydrochloride 54mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Oxpentifylline 400mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Ciprofloxacin 1000mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Sulfasalazine 500mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Oxycodone hydrochloride 160mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Metformin hydrochloride 1g m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| furosemida+potasio 40 mg/8 mmol, comprimido de liberación modificada |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Metoclopramide hydrochloride 15mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Metoprolol succinate 50mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Carbidopa + levodopa 50mg/200mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| furosemida+potasio, 20 mg/10 mmol, comprimido de liberación modificada |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Amoxicillin + clavulanate potassium 1g/62.5mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Glipizide 2.5mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| bendrofluazida+potasio, 2,5 mg/7,7 mmol, comprimido de liberación modificada (producto) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Theophylline, anhydrous 600mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| dinitrato de isosorbida, 40 mg, comprimido de liberación modificada (producto) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Cetirizine hydrochloride + pseudoephedrine 5mg/120mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Tramadol hydrochloride 300mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Aspirin 650mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Nifedipine 20mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Tramadol hydrochloride 75mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Diltiazem 180mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Aspirin 800mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| bumetanida+potasio 500 mcg/7,7 mmol, comprimido de liberación modificada |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Metformin hydrochloride 750mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Nisoldipine 40mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Glipizide 5mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Diltiazem 300mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Diltiazem 120mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Diltiazem 240mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Oxycodone hydrochloride 30mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Oxycodone hydrochloride 15mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Oxycodone hydrochloride 60mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Divalproex sodium 500mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Mirabegron 25mg m/r tablet |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Mirabegron 50mg m/r tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Tacrolimus 750microgram modified-release tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Tacrolimus 4mg modified-release tablet |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Tacrolimus 1mg modified-release tablet (product) |
Has manufactured dose form |
False |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Prolonged-release oral tablet |
es un[a] |
True |
Modified-release oral tablet (dose form) |
relación inferida |
restricción existencial (metadato del núcleo) |
|